1. Long-term efficacy and safety of obeticholic acid in patients with PBC from the POISE trial grouped biochemically by risk of disease progression. (March 2021) Authors: Bowlus, C.L.; Trauner, M.; Liberman, A.; Malecha, E.; MacConell, L.; Kremer, A.E.; Nevens, F.; Floreani, A. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC.04.7 LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PBC FROM THE POISE TRIAL GROUPED BIOCHEMICALLY BY RISK OF DISEASE PROGRESSION. (September 2021) Authors: Floreani, A.; Bowlus, C.L.; Trauner, M.; Malecha, E.; Kremer, A.E.; Nevens, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗